Her research interests are in health economics and public finance. Her recent work has focused on the pharmaceutical market. In this area of research, she has studied Medicaid reimbursement policies, Medicaid managed care, Medicare Part D, direct-to-consumer advertising, opioid abuse, and drug shortages. Prior to joining Wharton, she was an Assistant Professor of Economics and Public Policy at The Paul Merage School of Business at the University of California in Irvine, and she was an Associate Economist at the RAND Corporation. She received her PhD in Economics from the University of Maryland and BS in Mathematics and Economics from the University of Chicago.